Form D · Biotechnology
Allakos Inc.
San Carlos, CA · CIK 0001564824
Offering snapshot reported Dec 18, 2017 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 30, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 18, 2017 | Initial | $100,141,456 | No comparison | 40 | SEC filing |
| Mar 25, 2015 | Amendment | $27,949,545 | $3,404,093vs Aug 27, 2014 | 12 | SEC filing |
| Aug 27, 2014 | Amendment | $24,545,452 | $14,545,455vs Dec 20, 2012 | 6 | SEC filing |
| Dec 20, 2012 | Initial | $9,999,997 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-300963
Source: Form D, filed Dec 18, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Alexander | Director, Executive |
| Christopher Bebbington | Director, Executive |
| Farah Champsi | Director |
| Alejandro Dorenbaum | Executive |
| Steve James | Director |
| Dan Janney | Director |
| John Mc Kearn | Director |
| Peter Moldt | Director |
| Nenad Tomasevic | Executive |
| Adam Tomasi | Executive |
| Paul Walker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
75 Shoreway Road, Suite A
San Carlos, CA, 94070
San Carlos, CA, 94070